Differential immune induction with subcutaneous versus oral administration of a diabetogenic insulin peptide in the NOD mouse.
The B chain insulin peptide 9 to 23 (B:9-23) is a dominant T cell epitope of the NOD mouse. Given in oral form with multiple different vehicles, it did not alter expression of insulin autoantibodies in contrast to subcutaneous administration.